Juncos L A, Garvin J, Carretero O A, Ito S
Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan 48202, USA.
J Clin Invest. 1995 Jun;95(6):2741-8. doi: 10.1172/JCI117977.
Flow may be a physiological stimulus of the endothelial release of nitric oxide (NO) and prostaglandins (PGs). We tested the hypothesis that pressure-induced constriction of the glomerular afferent arteriole (Af-Art) is modulated by luminal flow via endothelial production of NO. We microdissected the terminal segment of an interlobular artery together with two Af-Arts, their glomeruli (GL) and efferent arterioles (Ef-Art). The two Af-Arts were perfused simultaneously from the interlobular artery, while one Ef-Art was occluded. Since the arteriolar perfusate contained 5% albumin, oncotic pressure built up in the glomerulus with the occluded Ef-Art and opposed the force of filtration, resulting in little or no flow through the corresponding Af-Art. Thus this preparation allowed us to observe free-flow and no-flow Af-Arts simultaneously during stepwise 30-mmHg increases in intraluminal pressure (from 30 to 120 mmHg). Pressure-induced constriction was weaker in free-flow than no-flow Af-Arts, with the luminal diameter decreasing by 11.1 +/- 1.7 and 25.6 +/- 2.3% (n = 30), respectively, at 120 mmHg. To examine whether flow modulates myogenic constriction through endothelium-derived NO and/or PGs, we examined pressure-induced constriction before and after (a) disruption of the endothelium, (b) inhibition of NO synthesis with NW-nitro-L-arginine methyl ester (L-NAME), or (c) inhibition of cyclooxygenase with indomethacin. Both endothelial disruption and L-NAME augmented pressure-induced constriction in free-flow but not no-flow Af-Arts, abolishing the differences between the two. However, indomethacin had no effect in either free-flow or no-flow Af-Arts. These results suggest that intraluminal flow attenuates pressure-induced constriction in Af-Arts via endothelium-derived NO. Thus flow-stimulated NO release may be important in the fine control of glomerular hemodynamics.
血流可能是内皮细胞释放一氧化氮(NO)和前列腺素(PGs)的一种生理刺激因素。我们检验了这样一个假说,即压力诱导的肾小球入球小动脉(Af-Art)收缩受管腔内血流通过内皮细胞产生的NO调节。我们显微解剖了一条小叶间动脉的终末段以及两条入球小动脉、它们的肾小球(GL)和出球小动脉(Ef-Art)。两条入球小动脉由小叶间动脉同时灌注,而其中一条出球小动脉被阻断。由于动脉灌注液中含有5%的白蛋白,被阻断出球小动脉的肾小球内形成了胶体渗透压,对抗滤过力,导致相应入球小动脉几乎没有或没有血流。因此,这种制备方法使我们能够在管腔内压力逐步升高30 mmHg(从30至120 mmHg)期间同时观察到有血流和无血流的入球小动脉。压力诱导的收缩在有血流的入球小动脉中比无血流的入球小动脉中更弱,在120 mmHg时,管腔直径分别减小11.1±1.7%和25.6±2.3%(n = 30)。为了研究血流是否通过内皮源性NO和/或PGs调节肌源性收缩,我们在以下情况前后检查了压力诱导的收缩:(a)内皮细胞破坏;(b)用Nω-硝基-L-精氨酸甲酯(L-NAME)抑制NO合成;或(c)用吲哚美辛抑制环氧化酶。内皮细胞破坏和L-NAME均增强了有血流但非无血流的入球小动脉中压力诱导的收缩,消除了两者之间的差异。然而,吲哚美辛对有血流或无血流的入球小动脉均无影响。这些结果表明,管腔内血流通过内皮源性NO减弱了入球小动脉中压力诱导的收缩。因此,血流刺激的NO释放可能在肾小球血流动力学的精细调节中起重要作用。